Skip to main content
Caplight Logo









PrecisionPhage

PrecisionPhage

Private
JyväskyläHealthcare & Life Scienceshttps://www.precisionphage.com/

Last Round

VC Round

May 1, 2026

Total Funding Raised

$2.29M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PrecisionPhage is a biotechnology company that provides phage bioinformatics software, laboratory services, and an extensive phage library to combat antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Data as a Service, Freemium, Government Contracts

AI Layer

Application

Keywords

antimicrobial resistanceAMRbacteriophagephage therapybioinformatics softwarephage genomicsAI drug discoveryGMP softwarephage manufacturingphage librarybioinformatics SaaScontract research organizationCROphage cocktail designcomputational biologygenome annotation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PrecisionPhage Comparables

Compare PrecisionPhage with similar companies based on industry and business-model similarity.

PrecisionPhage comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PhageAI S.A.
83%
Rime Bioinformatics
82%
Medea Biopharma
69%

PrecisionPhage Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 1, 2026
SeedNov 12, 2024
GrantNov 12, 2024

Key People

Founding team and executive leadership

Matti Jalasvuori

Chief Executive Officer

Executive Team

PrecisionPhage Investors

Notable investors and investment history

PrecisionPhage investors
InvestorRounds
Nordic Science InvestmentsSeed
Unifund Jyväskylä OySeed
Business FinlandGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2026

    Completed a VC Round funding round.

  • Feb 22, 2026

    Grew 50% QoQ from 8 to 12 employees.

PrecisionPhage Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PrecisionPhage Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PrecisionPhage's valuation, stock price, and market status.

Firmographic Details

HeadquartersJyväskylä
Employee Range14
Year Founded2022
Last FundingMay 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?